Repeated opening of the blood-brain barrier with the skull-implantable SonoCloud-9 (SC9) device: Phase 1 trial of nab-paclitaxel and SC9 in recurrent glioblastoma.

Authors

null

Adam M. Sonabend

Northwestern Medicine Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, Chicago, IL

Adam M. Sonabend , Andrew Gould , Yu Luan , Ye Hou , Li Chen , Mikoto A. Kobayashi , Brandyn A. Castro , Daniel Y. Zhang , Farida V. Korobova , Christina Amidei , John F. Bebawy , Benjamin P Liu , Craig M. Horbinski , Carole Desseaux , Irene B. Helenowski , Hui Zhang , Miguel M Muzzio , Feng Yue , Michael Canney , Roger Stupp

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Glioma

Clinical Trial Registration Number

NCT04528680

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 2016)

DOI

10.1200/JCO.2022.40.16_suppl.2016

Abstract #

2016

Poster Bd #

354

Abstract Disclosures